{ "ok": true, "cik": "811222", "ticker": "CDIX", "name": "CARDIFF LEXINGTON CORPORATION", "filings": [ { "form": "8-K", "filed": "2026-09-04", "items": [ "3.03 Material Modifications to Rights of Security Holders", "5.03 Amendments to Articles or Bylaws; Change in Fiscal Year", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/811222/000168316826006974/0001683168-26-006974-index.htm" }, { "form": "10-Q", "filed": "2026-08-12", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/811222/000168316826006232/0001683168-26-006232-index.htm" }, { "form": "S-1", "filed": "2026-06-11", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/811222/000168316826004763/0001683168-26-004763-index.htm" }, { "form": "8-K", "filed": "2026-06-11", "items": [ "1.01 Entry into a Material Definitive Agreement", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/811222/000168316826004756/0001683168-26-004756-index.htm" }, { "form": "10-Q", "filed": "2026-05-13", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/811222/000168316826003791/0001683168-26-003791-index.htm" }, { "form": "10-K", "filed": "2026-03-10", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/811222/000168316826001639/0001683168-26-001639-index.htm" } ], "events12m": 4, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000811222.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=811222" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up CARDIFF LEXINGTON CORPORATION ($CDIX). Last filing: 8-K (3.03 Material Modifications to Rights of Security Holders), 2026-09-04. 4 event filings (8-K) in the past twelve months. Non-reliance (8-K Item 4.02) filed 2025-08-14.", "auditor": { "changes": [], "nonReliance": [ { "filed": "2025-08-14", "url": "https://www.sec.gov/Archives/edgar/data/811222/000168316825006130/0001683168-25-006130-index.htm" }, { "filed": "2024-10-17", "url": "https://www.sec.gov/Archives/edgar/data/811222/000168316824007190/0001683168-24-007190-index.htm" } ], "restatedSince": true }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 11535577, "revenueGrowth1y": 0.3948490023005695, "revenueGrowthPerYear": 0.03951547227318519, "yearsOfData": 5, "operatingMargin": 0.09540797135678605, "operatingMarginPrior": -0.023397950647910323, "netMargin": -0.47744399781649416, "operatingCashFlow": null, "capitalSpending": null, "freeCashFlow": null, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 318535, "longTermDebt": 18560158, "longTermDebtChange": 1.0152407801347594, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 9879057 }, { "fiscalYearEnd": "2022-12-31", "revenue": 10693196 }, { "fiscalYearEnd": "2023-12-31", "revenue": 11853266 }, { "fiscalYearEnd": "2024-12-31", "revenue": 8270126 }, { "fiscalYearEnd": "2025-12-31", "revenue": 11535577 } ], "totalEquity": -2469661, "totalAssets": 29086945, "equityRatio": -0.08490616666686722, "returnOnEquity": null, "dividendsPaid": 50000, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "range80": { "low": 10245704.701362222, "high": 18397315.241116144, "baseline": 13960627.744055351, "n": 749, "band": "b00" }, "ifPaceHeld": { "low": 10245704.701362222, "high": 18397315.241116144 } }, "edgarette": "🔖 Exposure: revenue $11.5M (FY2025), total debt $18.6M. Experience: revenue up 39.5% on the year, up 4.0% a year over 4 years; operating margin 9.5%, up from -2.3%. Soundness: equity -8.5% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $10.2M and $18.4M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (54 filers, $50M+ revenue, its industry group): operating margin 9.5% against a 2.0% median; growth 39.5% against 13.0%.", "peers": { "sic": 8011, "sicDescription": "Services-Offices & Clinics of Doctors of Medicine", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "80", "growth": [ 0.1303, 61 ], "opMargin": [ 0.0199, 54 ], "equityRatio": [ 0.4419, 59 ], "returnOnEquity": [ 0.0155, 49 ], "payoutRatio": [ 0.1928, 13 ] }, "summary": "Cardiff Lexington (CDIX) grew revenue 39.5% in FY2025 to $12 million, operating margin 9.5% against a 2.0% median for services-offices & clinics of doctors of medicine, equity -8.5% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
CARDIFF LEXINGTON CORPORATION against its own record and its peers
Operating marginPeer median 2.0%9.5%Revenue, on the yearPeer median 13.0%39.5%Equity of assetsPeer median 44.2%-8.5%Gold tick: the median of 59–59 peers with $50M+ revenue in services-offices & clinics of doctors of medicine
", "chartHorizon": null, "backtest": { "tests": 9, "hits": 2, "rate": 0.2222222222222222, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T14:11:18.077Z", "hash": "7e565180d9cdbe1e", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Cardiff Lexington (CDIX) grew revenue 39.5% in FY2025 to $12 million, operating margin 9.5% against a 2.0% median for services-offices & clinics of doctors of medicine, equity -8.5% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 11535577, "totalDebt": 18560158, "cash": 318535 }, "experience": { "revenueGrowth1y": 0.3948490023005695, "revenueGrowthPerYear": 0.03951547227318519, "operatingMargin": 0.09540797135678605, "operatingMarginPrior": -0.023397950647910323, "netMargin": -0.47744399781649416, "freeCashFlow": null }, "soundness": { "equityRatio": -0.08490616666686722, "returnOnEquity": null, "payoutRatio": null, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 8011, "sicDescription": "Services-Offices & Clinics of Doctors of Medicine", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "80", "growth": [ 0.1303, 61 ], "opMargin": [ 0.0199, 54 ], "equityRatio": [ 0.4419, 59 ], "returnOnEquity": [ 0.0155, 49 ], "payoutRatio": [ 0.1928, 13 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": { "filed": "2025-08-14", "url": "https://www.sec.gov/Archives/edgar/data/811222/000168316825006130/0001683168-25-006130-index.htm", "restatedSince": true, "markedDown": false }, "auditorChange": null }, "range": { "low": 10245704.701362222, "high": 18397315.241116144, "baseline": 13960627.744055351, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 749, "sizeBand": "b00" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 9, "hits": 2, "rate": 0.2222222222222222, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T14:11:18.077Z", "hash": "7e565180d9cdbe1e", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000811222.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=811222" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }